Successful Rescue of Life-threatening Hemoptysis Caused by Pulmonary Tuberculosis Bridging with Extracorporeal Membrane Oxygenation

Intern Med. 2022 Dec 1;61(23):3611-3615. doi: 10.2169/internalmedicine.8558-21. Epub 2022 Apr 9.

Abstract

Massive hemoptysis is a fatal complication associated with pulmonary tuberculosis (TB). It can lead to severe respiratory failure. Extracorporeal membrane oxygenation (ECMO) is a life-saving technology that is rarely indicated for bleeding disorders. We herein report a 26-year-old man who presented with severe respiratory failure caused by massive hemoptysis with pulmonary TB. Transcatheter artery embolization was successfully performed with venovenous ECMO support. The hemostatic procedure allowed concomitant anticoagulant use, and neither bleeding nor thrombotic complications occurred throughout the clinical course. Administering the appropriate hemostatic procedure with subsequent management, including anticoagulant therapy, supported ECMO application in a case of bleeding.

Keywords: anticoagulant therapy; extracorporeal membrane oxygenation; massive hemoptysis; transcatheter artery embolization; tuberculosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Extracorporeal Membrane Oxygenation*
  • Hemoptysis / drug therapy
  • Hemoptysis / therapy
  • Hemorrhage / drug therapy
  • Hemostatics*
  • Humans
  • Male
  • Respiratory Insufficiency* / complications
  • Respiratory Insufficiency* / therapy
  • Tuberculosis, Pulmonary* / complications
  • Tuberculosis, Pulmonary* / drug therapy

Substances

  • Anticoagulants
  • Hemostatics